Education
About Us
Working with TipRanks
Follow Us
ARCH Venture Partners XII, LLC Insider Profile
11 Followers
ARCH Venture Partners XII, LLC, Ten Percent Owner at Neumora Therapeutics, Inc., holds 8.31M shares in Metsera, Inc. (Ticker: MTSR), holds 3.73M shares in Rapport Therapeutics, Inc. (Ticker: RAPP), holds 15.46M shares in Prime Medicine, Inc. (Ticker: PRME).
ARCH Venture Partners XII, LLC Neumora Therapeutics, Inc. (NMRA)Ten Percent Owner
Neumora Therapeutics, Inc. (NMRA)
Ten Percent Owner
Ranked #67,600 out of 100,443 Corporate Insiders
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
-8.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of ARCH Venture Partners XII, LLC's holdings
Insider Roles
Roles that ARCH Venture Partners XII, LLC holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 25, 2023 - Sep 25, 2024
Return:+12.20%
The most profitable trade made by ARCH Venture Partners XII, LLC
ARCH Venture Partners XII, LLC's Trading History
Neumora Therapeutics, Inc.
Dec 12, 2023
Ten Percent Owner
Uninformative Buy
―
$59.39M
Prime Medicine, Inc.
Feb 20, 2024
Ten Percent Owner
Informative Buy
20.00M
$40.96M
Rapport Therapeutics, Inc.
Jun 10, 2024
Ten Percent Owner
Uninformative Buy
―
$61.90M
Metsera, Inc.
Feb 03, 2025
Ten Percent Owner
Uninformative Buy
―
$231.12M
List of latest transactions for each holding click on a transaction to see ARCH Venture Partners XII, LLC's performance on stock
You May Also Like
ARCH Venture Partners XII, LLC insider profile FAQ
What is the percentage of profitable transactions made by ARCH Venture Partners XII, LLC?
The percentage of profitable transactions made by ARCH Venture Partners XII, LLC is 43%.
What is the average return per transaction made by ARCH Venture Partners XII, LLC?
The average return per transaction made by ARCH Venture Partners XII, LLC is -8.40%.
What stocks does ARCH Venture Partners XII, LLC hold?
ARCH Venture Partners XII, LLC holds: NMRA, PRME, RAPP, MTSR stocks.
What was ARCH Venture Partners XII, LLC’s latest transaction?
ARCH Venture Partners XII, LLC latest transaction was an Uninformative Buy of ―.
What was ARCH Venture Partners XII, LLC's most profitable transaction?
ARCH Venture Partners XII, LLC’s most profitable transaction was an Informative Buy of NMRA stock on September 25, 2023. The return on the trade was 12.20%.
What is ARCH Venture Partners XII, LLC's role in Neumora Therapeutics, Inc.?
ARCH Venture Partners XII, LLC's role in Neumora Therapeutics, Inc. is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.